Cargando…
Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
Objectives: To explore the relationship between peripheral blood inflammation parameters and overall survival (OS) and progression-free survival (PFS) of early-stage non-small cell lung cancer patients who underwent stereotactic body radiotherapy (SBRT). Patients and methods: In this study, eligible...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857614/ https://www.ncbi.nlm.nih.gov/pubmed/36673123 http://dx.doi.org/10.3390/diagnostics13020313 |
_version_ | 1784873908473692160 |
---|---|
author | Dong, Baiqiang Zhu, Xuan Chen, Runzhe Wu, Qing Jin, Jia’nan Wang, Lin Xu, Yujin Chen, Ming |
author_facet | Dong, Baiqiang Zhu, Xuan Chen, Runzhe Wu, Qing Jin, Jia’nan Wang, Lin Xu, Yujin Chen, Ming |
author_sort | Dong, Baiqiang |
collection | PubMed |
description | Objectives: To explore the relationship between peripheral blood inflammation parameters and overall survival (OS) and progression-free survival (PFS) of early-stage non-small cell lung cancer patients who underwent stereotactic body radiotherapy (SBRT). Patients and methods: In this study, eligible patients treated with SBRT from 2013 to 2018, and both serum complete blood count and blood biochemical results were available prior to (within 60 days) radiotherapy were included. Results: A review of hospital registries identified 148 patients, and the 5-year OS and PFS of the entire cohort were 69.8% and 65.6%, respectively, with the median follow-up time was 52.8 months. Multivariable analysis showed that derived neutrophil-lymphocyte ratio (dNLR) ≥1.4 and C-reactive protein (CRP) ≥2.9 were statistically and independently associated with worse OS (HR = 4.62, 95% CI 1.89–11.27, p = 0.001; HR = 2.92, 95% CI 1.49–5.70, p = 0.002, respectively). The 5-year OS for patients with dNLR below and equal to or above the 1.4 were 85.3% and 62.9% (p = 0.002), respectively, and 76.7% for the low CRP group versus 58.5% for the high CRP group (p = 0.030). Higher serum level of post-treatment CRP also independent parameters for inferior PFS (HR = 4.83, 95% CI 1.28–18.25, p = 0.020). Conclusions: Our results demonstrate that dNLR and CRP are associated with the outcomes of early-stage NSCLC patients treated with SBRT, which may assist in selecting optimal nursing care and therapeutic scheme for every individual. |
format | Online Article Text |
id | pubmed-9857614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98576142023-01-21 Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy Dong, Baiqiang Zhu, Xuan Chen, Runzhe Wu, Qing Jin, Jia’nan Wang, Lin Xu, Yujin Chen, Ming Diagnostics (Basel) Article Objectives: To explore the relationship between peripheral blood inflammation parameters and overall survival (OS) and progression-free survival (PFS) of early-stage non-small cell lung cancer patients who underwent stereotactic body radiotherapy (SBRT). Patients and methods: In this study, eligible patients treated with SBRT from 2013 to 2018, and both serum complete blood count and blood biochemical results were available prior to (within 60 days) radiotherapy were included. Results: A review of hospital registries identified 148 patients, and the 5-year OS and PFS of the entire cohort were 69.8% and 65.6%, respectively, with the median follow-up time was 52.8 months. Multivariable analysis showed that derived neutrophil-lymphocyte ratio (dNLR) ≥1.4 and C-reactive protein (CRP) ≥2.9 were statistically and independently associated with worse OS (HR = 4.62, 95% CI 1.89–11.27, p = 0.001; HR = 2.92, 95% CI 1.49–5.70, p = 0.002, respectively). The 5-year OS for patients with dNLR below and equal to or above the 1.4 were 85.3% and 62.9% (p = 0.002), respectively, and 76.7% for the low CRP group versus 58.5% for the high CRP group (p = 0.030). Higher serum level of post-treatment CRP also independent parameters for inferior PFS (HR = 4.83, 95% CI 1.28–18.25, p = 0.020). Conclusions: Our results demonstrate that dNLR and CRP are associated with the outcomes of early-stage NSCLC patients treated with SBRT, which may assist in selecting optimal nursing care and therapeutic scheme for every individual. MDPI 2023-01-14 /pmc/articles/PMC9857614/ /pubmed/36673123 http://dx.doi.org/10.3390/diagnostics13020313 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dong, Baiqiang Zhu, Xuan Chen, Runzhe Wu, Qing Jin, Jia’nan Wang, Lin Xu, Yujin Chen, Ming Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy |
title | Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy |
title_full | Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy |
title_fullStr | Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy |
title_full_unstemmed | Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy |
title_short | Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy |
title_sort | derived neutrophil-lymphocyte ratio and c-reactive protein as prognostic factors for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857614/ https://www.ncbi.nlm.nih.gov/pubmed/36673123 http://dx.doi.org/10.3390/diagnostics13020313 |
work_keys_str_mv | AT dongbaiqiang derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy AT zhuxuan derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy AT chenrunzhe derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy AT wuqing derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy AT jinjianan derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy AT wanglin derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy AT xuyujin derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy AT chenming derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy |